earnings
saveVertex, Inc. earnings
community read0 votes
Anticipated earnings call for Vertex, Inc. ($VERX).
view source ↗Data sources
Found something off?
same company · ±60 days · 6
- phase 2 completionVX-993: Vertex Pharmaceuticals Inc — VX-993 (Phase II Trial Completion)Apr 30, 2026
- approvalTRIKAFTA (COPACKAGED): TRIKAFTA (COPACKAGED) (ELEXACAFTOR, IVACAFTOR, TEZACAFTOR) — FDA approvalMar 27, 2026
- approval(deutivacaftor + tezacaftor + vanzacaftor calcium): ALYFTREK (DEUTIVACAFTOR) — FDA approvalMar 27, 2026
- approvalTRIKAFTA (COPACKAGED): TRIKAFTA (COPACKAGED) (ELEXACAFTOR, IVACAFTOR, TEZACAFTOR) — FDA approvalMar 27, 2026
- approvalTRIKAFTA (COPACKAGED): TRIKAFTA (COPACKAGED) (ELEXACAFTOR, IVACAFTOR, TEZACAFTOR) — FDA approvalMar 17, 2026
- approvalivacaftor: SYMDEKO (COPACKAGED) (IVACAFTOR) — FDA approvalMar 17, 2026
comments(0)
5-min edit window · permanent after that